"Molten will subscribe for $1 million in equity capital in Panax, on terms consistent with Panax’s recent Pro-Rata Renounceable Rights Issue capital raising, being at an issue price of two cents per share, with attaching listed options on a one for two basis with a strike price of four cents per share and a three year term".
Maybe that is what is freaking them out, the fact that the price is 1.5c, rather than the 2c. I personally would rather have a partner that can meet their commitments.
PAX Price at posting:
1.4¢ Sentiment: LT Buy Disclosure: Held
